70 related articles for article (PubMed ID: 19236753)
21. Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpression.
Sasaki N; Kuroda J; Nagoshi H; Yamamoto M; Kobayashi S; Tsutsumi Y; Kobayashi T; Shimura Y; Matsumoto Y; Taki T; Nishida K; Horiike S; Akao Y; Taniwaki M
Exp Hematol; 2011 Aug; 39(8):817-28.e1. PubMed ID: 21640157
[TBL] [Abstract][Full Text] [Related]
22. [Expression of microRNA-223 and its clinicopathologic correlation in diffuse large B-cell lymphoma].
Yao XX; Wang JF; Wang YH; Gao N
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):366-70. PubMed ID: 22932402
[TBL] [Abstract][Full Text] [Related]
23. MiR-223 Suppresses Proliferation and Promotes Apoptosis of Diffuse Large B-Cell Lymphoma Cells Through Lmo2 and MAPK Signaling Pathway.
Zhang Y; Zhang J
J BUON; 2021; 26(2):580-586. PubMed ID: 34077008
[TBL] [Abstract][Full Text] [Related]
24. Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis.
Rossi D; Gaidano G
Hematology; 2002 Aug; 7(4):239-52. PubMed ID: 14972786
[TBL] [Abstract][Full Text] [Related]
25. MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.
Yoon SO; Jeon YK; Paik JH; Kim WY; Kim YA; Kim JE; Kim CW
Histopathology; 2008 Aug; 53(2):205-17. PubMed ID: 18752503
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas.
King BE; Chen C; Locker J; Kant J; Okuyama K; Falini B; Swerdlow SH
Mod Pathol; 2000 Nov; 13(11):1219-31. PubMed ID: 11106080
[TBL] [Abstract][Full Text] [Related]
27. [Mechanism and clinical significance of anti-apoptotic gene bcl-2 expression in diffuse large B-cell lymphoma].
Zeng LP; Wen YL; Ma Y; Wang GQ; Li Y; Wang J; Xu LL; Zhang XM
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):377-81. PubMed ID: 21914345
[TBL] [Abstract][Full Text] [Related]
28. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
[TBL] [Abstract][Full Text] [Related]
29. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
[TBL] [Abstract][Full Text] [Related]
30. [Large-cell diffuse B-cell lymphoma: heterogenous origin and prognosis from the aspect of modern diagnosis].
Soukup J; Krsková L; Mrhalová M; Kodet R; Campr V; Kubácková K; Trnĕný M
Cas Lek Cesk; 2003; 142(7):417-22. PubMed ID: 14515445
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma.
Gu L; Song G; Chen L; Nie Z; He B; Pan Y; Xu Y; Li R; Gao T; Cho WC; Wang S
Acta Haematol; 2013; 130(2):87-94. PubMed ID: 23548551
[TBL] [Abstract][Full Text] [Related]
32. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
Ree HJ; Yang WI; Kim CW; Huh J; Lee SS; Cho EY; Ko YH; Charney D
Hum Pathol; 2001 Sep; 32(9):954-62. PubMed ID: 11567225
[TBL] [Abstract][Full Text] [Related]
33. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
[TBL] [Abstract][Full Text] [Related]
34. [Detection of t (14; 18) translocation and bcl-2 amplification in diffuse large B-cell lymphoma].
Jiang HY; Li HL; Hu H; He Y; Zhao T
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):84-9. PubMed ID: 17493380
[TBL] [Abstract][Full Text] [Related]
35. Case Report: Identification of Potential Prognosis-Related
Zhang Y; Ma L; Liu J; Zhu H; Lu L; Deng K; Ma W; Pan H; Wang R; Yao Y
Front Endocrinol (Lausanne); 2021; 12():673908. PubMed ID: 34381423
[TBL] [Abstract][Full Text] [Related]
36. Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma (DLBCL).
Nedomova R; Papajik T; Prochazka V; Indrak K; Jarosova M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Sep; 157(3):239-47. PubMed ID: 23132512
[TBL] [Abstract][Full Text] [Related]
37. Mutational analysis of the 5' noncoding region of the bcl-6 gene in primary gastric lymphomas.
Go JH; Yang WI; Ree HJ
Mod Pathol; 2001 May; 14(5):410-4. PubMed ID: 11353050
[TBL] [Abstract][Full Text] [Related]
38. Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone.
Wu PY; Zhang XD; Zhu J; Guo XY; Wang JF
Hum Pathol; 2014 Aug; 45(8):1664-73. PubMed ID: 24931464
[TBL] [Abstract][Full Text] [Related]
39. Diabetes mellitus potentiates diffuse large B‑cell lymphoma via high levels of CCL5.
Zhang J; Luo J; Liu F; Wu D; Zhong Q; Zeng L; Wu Z; Zhao T; Wu L; Hao H
Mol Med Rep; 2014 Sep; 10(3):1231-6. PubMed ID: 24938715
[TBL] [Abstract][Full Text] [Related]
40. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma.
Offit K; Lo Coco F; Louie DC; Parsa NZ; Leung D; Portlock C; Ye BH; Lista F; Filippa DA; Rosenbaum A
N Engl J Med; 1994 Jul; 331(2):74-80. PubMed ID: 8208268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
